Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.
AUTOR(ES)
Jacobsen, H
RESUMO
We have evaluated a possible role for human immunodeficiency virus type 1 protease during early steps of replication. For these studies, a specific inhibitor of human immunodeficiency virus protease, Ro31-8959, was used. Synthesis of viral cDNA, its integration into cellular DNA, and its transcription were determined during a one-step, acute infection of MT-4 cells. No consistent difference in any of these parameters was noted between control-infected cultures and those treated with protease inhibitor. However, no infectious progeny virus was produced in treated cultures, and thus spread of infection was severely restricted. Our results do not support an essential activity of viral protease in early steps of replication but are in line with its established role in gag and gag-pol processing and in maturation to infectious progeny virus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=241373Documentos Relacionados
- Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease.
- Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
- Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.
- Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
- Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease.
